Table 4 Odds of Receiving Blood Products in the Pre-Quantra and Post-Quantra Cohorts
From: Retrospective study assessing outcomes in cardiac surgery after implementation of Quantra
pRBC | FFP | Platelets | Cryoprecipitate | |
|---|---|---|---|---|
OR (CI) | OR (CI) | OR (CI) | OR (CI) | |
Pre-Quantra | 1)1.00 (0.42, 2.37) 2)1.58 (0.53, 4.74) | 1)17.64 (2.24, 138.75)* 2) 37.04 (2.16, 636.0)* | 1)0.80 (0.32, 2.02) 2)1.93 (0.61, 6.12) | 1)1.00 (0.19, 5.15) 2)7.34 (0.37, 145.1) |
Post-Quantra | 1)1.00 (0.42, 2.37) 2)0.63 (0.21, 1.89) | 1)0.06 (0.01, 0.45) * 2)0.03 (0.02, 0.46)* | 1)1.25 (0.50, 3.131) 2)0.52 (0.16, 1.64) | 1)1.00 (0.19, 5.15) 2)0.14 (0.07, 2.69) |